Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-07-20 , DOI: 10.1111/1759-7714.14083
Donghui Hou ₁ , Xiaomin Zheng ₂ , Wei Song ₃ , Xiaoqing Liu ₄ , Sicong Wang ₅ , Lina Zhou ₁ , Xiuli Tao ₆ , Lv Lv ₆ , Qi Sun ₇ , Yujing Jin ₆ , Zewei Zhang ₆ , Lieming Ding ₈ , Ning Wu _{1,

6} , Shijun Zhao ₁

Affiliation

Here, we aimed to assess the association of ALK variants and alterations with ensartinib response duration in NSCLC, and explore the potential value of computed tomography (CT) radiomic features in predicting progression-free survival (PFS).

中文翻译：